BridgeMD
New treatment option for All Types of Pediatric Cancer
Official title Cardiorespiratory Fitness in Children and Adolescents After Cancer Treatment.
ClinicalTrials.gov ID: NCT04765020
What this study is testing
- What it's testing
- The POWER-study is a two-arm exercise intervention study for pediatric patients following acute cancer treatment. This clinical trial will investigate the effects of a 12-week moderate to high-intensity exercise program on cardiorespiratory fitness in children and adolescents beginning 6 weeks after completion of acute cancer treatment.
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 7 to 23
You may be able to join if
- Children and adolescents between 7 and 23 years of age
- Completion of acute cancer treatment and receiving follow-up care in Krefeld (Helios Hospital Krefeld)
- 6 weeks post cancer-treatment
- Signed informed consent (Parents and Patient)
You likely can't join if
- \ 23 years of age
- Medical condition that limits participation in one of the study arms
- Inability to follow the training-protocol
- Inability to carry out the spiroergometry on a cycle ergometer
The study team makes the final eligibility decision.
Where it's taking place
- Krefeld, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 7 years to 23 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Krefeld, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.